Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
9
|
pubmed:dateCreated |
1977-6-30
|
pubmed:abstractText |
The concentration of plasma adenosine 3',5'-cyclic monophosphate (cyclic AMP) and plasma renin activity (PRA) were measured concomitantly in blood from both renal veins and in arterial blood in 22 hypertensive patients. In the nine patients with true renovascular hypertension the concentration of plasma cyclic AMP was greater in the venous effluent of the kidney affected by the renal artery stenosis than in that of the unaffected or less affected kidney. The arteriovenous difference in cyclic AMP concentration was less on the affected side in all but one patient. The arteriovenous differences in PRA identified the affected kidney as the source of hyper-reninemia and showed that renin release from the other kidney was suppressed. In the 13 patients with hypertension associated with but unrelated to renal artery stenosis there were no consistent patterns of cyclic AMP concentration or PRA in the venous effluent of the kidneys or of their arteriovenous differences. In renovascular hypertension the venous effluent of the kidney affected by renal artery stenosis contains not only more renin but also more cyclic AMP, owing to either increased cyclic AMP production or decreased excretion or extraction of cyclic AMP by the affected kidney. This unilateral increase in cyclic AMP concentration may become a complementary diagnostic feature of true renovascular hypertension.
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/192429-13057644,
http://linkedlifedata.com/resource/pubmed/commentcorrection/192429-14111716,
http://linkedlifedata.com/resource/pubmed/commentcorrection/192429-163152,
http://linkedlifedata.com/resource/pubmed/commentcorrection/192429-168232,
http://linkedlifedata.com/resource/pubmed/commentcorrection/192429-4304350,
http://linkedlifedata.com/resource/pubmed/commentcorrection/192429-4318781,
http://linkedlifedata.com/resource/pubmed/commentcorrection/192429-4319700,
http://linkedlifedata.com/resource/pubmed/commentcorrection/192429-4354650,
http://linkedlifedata.com/resource/pubmed/commentcorrection/192429-4357610,
http://linkedlifedata.com/resource/pubmed/commentcorrection/192429-4369018,
http://linkedlifedata.com/resource/pubmed/commentcorrection/192429-4383912,
http://linkedlifedata.com/resource/pubmed/commentcorrection/192429-6058099
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0008-4409
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
7
|
pubmed:volume |
116
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
992-6
|
pubmed:dateRevised |
2009-11-18
|
pubmed:meshHeading |
pubmed-meshheading:192429-Cyclic AMP,
pubmed-meshheading:192429-Female,
pubmed-meshheading:192429-Humans,
pubmed-meshheading:192429-Hypertension, Renal,
pubmed-meshheading:192429-Male,
pubmed-meshheading:192429-Middle Aged,
pubmed-meshheading:192429-Renal Artery,
pubmed-meshheading:192429-Renal Artery Obstruction,
pubmed-meshheading:192429-Renin
|
pubmed:year |
1977
|
pubmed:articleTitle |
Renal vein plasma adenosine 3',5'-cyclic monophosphate in renovascular hypertension.
|
pubmed:publicationType |
Journal Article
|